420 related articles for article (PubMed ID: 33448321)
21. Serum miR-30d as a novel biomarker for multiple myeloma and its antitumor role in U266 cells through the targeting of the MTDH/PI3K/Akt signaling pathway.
Zhu B; Chen H; Zhang X; Pan Y; Jing R; Shen L; Wang X; Ju S; Jin C; Cong H
Int J Oncol; 2018 Nov; 53(5):2131-2144. PubMed ID: 30132507
[TBL] [Abstract][Full Text] [Related]
22. Research on miR-126 in glioma targeted regulation of PTEN/PI3K/Akt and MDM2-p53 pathways.
Chen SR; Cai WP; Dai XJ; Guo AS; Chen HP; Lin GS; Lin RS
Eur Rev Med Pharmacol Sci; 2019 Apr; 23(8):3461-3470. PubMed ID: 31081101
[TBL] [Abstract][Full Text] [Related]
23. Long Noncoding RNA lncARSR Promotes Doxorubicin Resistance in Hepatocellular Carcinoma via Modulating PTEN-PI3K/Akt Pathway.
Li Y; Ye Y; Feng B; Qi Y
J Cell Biochem; 2017 Dec; 118(12):4498-4507. PubMed ID: 28464252
[TBL] [Abstract][Full Text] [Related]
24. Sevoflurane inhibits the proliferation and invasion of hepatocellular carcinoma cells through regulating the PTEN/Akt/GSK‑3β/β‑catenin signaling pathway by downregulating miR‑25‑3p.
Cao Y; Lv W; Ding W; Li J
Int J Mol Med; 2020 Jul; 46(1):97-106. PubMed ID: 32319540
[TBL] [Abstract][Full Text] [Related]
25. MicroRNA-130b targets PTEN to mediate drug resistance and proliferation of breast cancer cells via the PI3K/Akt signaling pathway.
Miao Y; Zheng W; Li N; Su Z; Zhao L; Zhou H; Jia L
Sci Rep; 2017 Feb; 7():41942. PubMed ID: 28165066
[TBL] [Abstract][Full Text] [Related]
26. SPAG6 promotes cell proliferation and inhibits apoptosis through the PTEN/PI3K/AKT pathway in Burkitt lymphoma.
Zhang R; Zhu H; Yuan Y; Wang Y; Tian Z
Oncol Rep; 2020 Nov; 44(5):2021-2030. PubMed ID: 33000212
[TBL] [Abstract][Full Text] [Related]
27. Repression of microRNA-21 inhibits retinal vascular endothelial cell growth and angiogenesis via PTEN dependent-PI3K/Akt/VEGF signaling pathway in diabetic retinopathy.
Lu JM; Zhang ZZ; Ma X; Fang SF; Qin XH
Exp Eye Res; 2020 Jan; 190():107886. PubMed ID: 31759996
[TBL] [Abstract][Full Text] [Related]
28. Alpha1-ACT Functions as a Tumour Suppressor in Hepatocellular Carcinoma by Inhibiting the PI3K/AKT/mTOR Signalling Pathway via Activation of PTEN.
Zhu H; Liu Q; Tang J; Xie Y; Xu X; Huang R; Zhang Y; Jin K; Sun B
Cell Physiol Biochem; 2017; 41(6):2289-2306. PubMed ID: 28456796
[TBL] [Abstract][Full Text] [Related]
29. Antitumor activity of celastrol by inhibition of proliferation, invasion, and migration in cholangiocarcinoma via PTEN/PI3K/Akt pathway.
Zhu B; Wei Y
Cancer Med; 2020 Jan; 9(2):783-796. PubMed ID: 31957323
[TBL] [Abstract][Full Text] [Related]
30. MicroRNA-196a promotes cell proliferation and inhibits apoptosis in human ovarian cancer by directly targeting DDX3 and regulating the PTEN/PI3K/AKT signaling pathway.
Ni J; Chen L; Ling L; Wu M; Ren Q; Zhu W
Mol Med Rep; 2020 Aug; 22(2):1277-1284. PubMed ID: 32626994
[TBL] [Abstract][Full Text] [Related]
31. Downregulation of microRNA‑198 suppresses cell proliferation and invasion in retinoblastoma by directly targeting PTEN.
Wei D; Miao Y; Yu L; Wang D; Wang Y
Mol Med Rep; 2018 Jul; 18(1):595-602. PubMed ID: 29749457
[TBL] [Abstract][Full Text] [Related]
32. Overexpression of Circular RNA ciRS-7 Abrogates the Tumor Suppressive Effect of miR-7 on Gastric Cancer via PTEN/PI3K/AKT Signaling Pathway.
Pan H; Li T; Jiang Y; Pan C; Ding Y; Huang Z; Yu H; Kong D
J Cell Biochem; 2018 Jan; 119(1):440-446. PubMed ID: 28608528
[TBL] [Abstract][Full Text] [Related]
33. MicroRNA-155-5p promotes hepatocellular carcinoma progression by suppressing PTEN through the PI3K/Akt pathway.
Fu X; Wen H; Jing L; Yang Y; Wang W; Liang X; Nan K; Yao Y; Tian T
Cancer Sci; 2017 Apr; 108(4):620-631. PubMed ID: 28132399
[TBL] [Abstract][Full Text] [Related]
34. MicroRNA-1297 contributes to tumor growth of human breast cancer by targeting PTEN/PI3K/AKT signaling.
Liu C; Liu Z; Li X; Tang X; He J; Lu S
Oncol Rep; 2017 Oct; 38(4):2435-2443. PubMed ID: 28791363
[TBL] [Abstract][Full Text] [Related]
35. MiR-374b Promotes Proliferation and Inhibits Apoptosis of Human GIST Cells by Inhibiting PTEN through Activation of the PI3K/Akt Pathway.
Long ZW; Wu JH; Cai-Hong ; Wang YN; Zhou Y
Mol Cells; 2018 Jun; 41(6):532-544. PubMed ID: 29902839
[TBL] [Abstract][Full Text] [Related]
36. PTEN, but not SHIP and SHIP2, suppresses the PI3K/Akt pathway and induces growth inhibition and apoptosis of myeloma cells.
Choi Y; Zhang J; Murga C; Yu H; Koller E; Monia BP; Gutkind JS; Li W
Oncogene; 2002 Aug; 21(34):5289-300. PubMed ID: 12149650
[TBL] [Abstract][Full Text] [Related]
37. JQ1 suppresses tumor growth via PTEN/PI3K/AKT pathway in endometrial cancer.
Qiu H; Li J; Clark LH; Jackson AL; Zhang L; Guo H; Kilgore JE; Gehrig PA; Zhou C; Bae-Jump VL
Oncotarget; 2016 Oct; 7(41):66809-66821. PubMed ID: 27572308
[TBL] [Abstract][Full Text] [Related]
38. Fibroblast-derived CXCL12 regulates PTEN expression and is associated with the proliferation and invasion of colon cancer cells via PI3k/Akt signaling.
Ma J; Sun X; Wang Y; Chen B; Qian L; Wang Y
Cell Commun Signal; 2019 Sep; 17(1):119. PubMed ID: 31500630
[TBL] [Abstract][Full Text] [Related]
39. Thidiazuron suppresses breast cancer via targeting miR-132 and dysregulation of the PI3K-Akt signaling pathway mediated by the miR-202-5p-PTEN axis.
Ibrahim HM; Ismail MB; Ammar RB; Ahmed EA
Biochem Cell Biol; 2021 Jun; 99(3):374-384. PubMed ID: 33103467
[TBL] [Abstract][Full Text] [Related]
40. miR-215-5p is an anticancer gene in multiple myeloma by targeting RUNX1 and deactivating the PI3K/AKT/mTOR pathway.
Liu S; Zhang Y; Huang C; Lin S
J Cell Biochem; 2020 Feb; 121(2):1475-1490. PubMed ID: 31498483
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
